Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the efficacy of ProLindac combined with paclitaxel in patients with advanced epithelial ovarian cancer, previously treated with cisplatin or carboplatin, who are potentially platinum-sensitive (platinum-free, progression-free interval 12 months)
Critère d'inclusion
- Advanced Ovarian Cancer